COST OF ILLNESS FOR CHRONIC KIDNEY DISEASE TREATMENT WITH HEMODIALYSIS IN YOGYAKARTA

I. Hadning, Muhammad Heyqal Wirakarsa, Muhamad Rinaldhi Tandah
{"title":"COST OF ILLNESS FOR CHRONIC KIDNEY DISEASE TREATMENT WITH HEMODIALYSIS IN YOGYAKARTA","authors":"I. Hadning, Muhammad Heyqal Wirakarsa, Muhamad Rinaldhi Tandah","doi":"10.20527/jbk.v18i1.12818","DOIUrl":null,"url":null,"abstract":"Abstract: The increase in the number of chronic kidney disease (CKD) sufferers and the expensive financing of this disease, the economic burden borne will certainly increase. This study aimed to determine the cost of illness of CKD patients undergoing hemodialysis, as well as to find out the comparison of real costs with INA-CBG’s rates. This was a pharmacoeconomic research, used the cost of illness method according to a societal perspective. The study was conducted in a type B government hospitals in Yogyakarta from January to March 2020. The population in this study were all CKD patients undergoing hemodialysis in need to mention the hospital at first. The research instruments were medical records, hospital financial data, and patient interviews. The complete data were analyzed statistically with the descriptive method and the Mann Whitney test. The number of samples was 65 patients. The results revealed the average cost of illness was 6,224,277.00 IDR for one month of treatment. The cost component that dominates was hemodialysis rate. The average real cost was 836,686 IDR for one procedure. It can be concluded that the average real cost of CKD patients with hemodialysis in the type B government hospital were significantly smaller than the INA-CBG’s rate.Keywords: Chronic Kidney Disease; Hemodialysis; Cost Of Illness; INA-CBG’s Rate ","PeriodicalId":53378,"journal":{"name":"Berkala Kedokteran","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Berkala Kedokteran","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.20527/jbk.v18i1.12818","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Abstract: The increase in the number of chronic kidney disease (CKD) sufferers and the expensive financing of this disease, the economic burden borne will certainly increase. This study aimed to determine the cost of illness of CKD patients undergoing hemodialysis, as well as to find out the comparison of real costs with INA-CBG’s rates. This was a pharmacoeconomic research, used the cost of illness method according to a societal perspective. The study was conducted in a type B government hospitals in Yogyakarta from January to March 2020. The population in this study were all CKD patients undergoing hemodialysis in need to mention the hospital at first. The research instruments were medical records, hospital financial data, and patient interviews. The complete data were analyzed statistically with the descriptive method and the Mann Whitney test. The number of samples was 65 patients. The results revealed the average cost of illness was 6,224,277.00 IDR for one month of treatment. The cost component that dominates was hemodialysis rate. The average real cost was 836,686 IDR for one procedure. It can be concluded that the average real cost of CKD patients with hemodialysis in the type B government hospital were significantly smaller than the INA-CBG’s rate.Keywords: Chronic Kidney Disease; Hemodialysis; Cost Of Illness; INA-CBG’s Rate 
YOGYAKARTA血液透析治疗慢性肾脏疾病的费用
摘要:随着慢性肾脏疾病(CKD)患者数量的增加和该病昂贵的治疗费用,所承担的经济负担必然会增加。本研究旨在确定CKD患者接受血液透析的疾病成本,并找出实际成本与INA-CBG率的比较。这是一项药物经济学研究,根据社会视角使用疾病成本方法。该研究于2020年1月至3月在日惹的一家B型政府医院进行。本研究人群均为需要首先提及医院的血液透析CKD患者。研究工具是医疗记录、医院财务数据和患者访谈。采用描述性方法和Mann Whitney检验对完整资料进行统计学分析。样本数量为65例。结果显示,一个月的平均治疗费用为6,224,277.00印尼盾。占主导地位的成本成分是血液透析率。一次手术的平均实际成本为836,686印尼盾。由此可见,在B型政府医院进行血液透析的CKD患者的平均实际成本明显小于INA-CBG率。关键词:慢性肾病;血液透析;疾病费用;INA-CBG的速度
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
审稿时长
24 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信